CBIO vs PG · $491.3M cap vs P/E 25, rev $84.28B
Crescent Biopharma, Inc. (CBIO) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
CBIO does not have a complete income-statement cache yet.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
CBIO currently screens at market cap $491.3M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the CBIO and PG stock pages for the full models.
Not investment advice.